I am new to this forum, but do a science commentary on another. I am doing due diligence on RCE before a buy.
Dosdogs, you state a problem with Z rings interference v human cells v gram - ve / gram + infections.
I don't believe it's an issue. In that the z ring is targeted by the Z inhibitor drug R 327. The cells of the gram infections are like a scaffold with the R 327 target being one of the electrical switches primarily number 1 switchbox. The Z inhibitor switches off said box allowing for a cell division thus cell death.
In humans the SlmA protein protects the cells that use z ring synthesis. The sepsis bacteria is not protected by SlmA protein.
Happy to discuss.
Ref : Recent progress in development of small molecule FtsZ inhibitors .Carro et Al 2019
Discovery of anti TB agents that target cell division protein FtsZ . Kumar et Al
Cell division protein FtsZ : From structure and mechanism to antibiotic target. Silver et al 2020.
RCE Price at posting:
77.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)